Resistance to in PTEN-null HER-overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3'-kinase/Akt pathway signaling - She, QB; Solit, D; Basso, A (Clin Cancer Res, 2003)
et al.